Cell Line : NCI-H2171
Cellosaurus Index : CVCL_1536
Cellosaurus ID : NCI-H2171
GDSC1 Name
, GDSC2 Name
: NCI-H2171
CCLE Name
: NCIH2171_LUNG
CTRP2 Name
: NCIH2171
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H2171 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| NCI-H2171 | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H2171 | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | AA-COCF3 | CTRP2 | 0.0010 | 2.1000 |
|
| NCI-H2171 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Afatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H2171 | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H2171 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| NCI-H2171 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H2171 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H2171 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| NCI-H2171 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| NCI-H2171 | Axitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| NCI-H2171 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| NCI-H2171 | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | AZD4547 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | AZD7762 | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H2171 | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H2171 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H2171 | Belinostat | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BI-2536 | GDSC1,GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| NCI-H2171 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H2171 | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H2171 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| NCI-H2171 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| NCI-H2171 | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H2171 | Bosutinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| NCI-H2171 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K33199242 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H2171 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H2171 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H2171 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H2171 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| NCI-H2171 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | BX795 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H2171 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | CCT007093 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H2171 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H2171 | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H2171 | Ch-55 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H2171 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H2171 | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| NCI-H2171 | COL-3 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H2171 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| NCI-H2171 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Crizotinib | GDSC1,GDSC2 | 0.0040 | 8.0000 |
|
| NCI-H2171 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H2171 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Dabrafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H2171 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H2171 | Dactolisib | GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| NCI-H2171 | Daporinad | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | Dasatinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H2171 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H2171 | Docetaxel | GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| NCI-H2171 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | Doramapimod | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | EHT-1864 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Elesclomol | GDSC2 | 0.0002 | 0.2000 |
|
| NCI-H2171 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H2171 | Entinostat | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| NCI-H2171 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Erlotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H2171 | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H2171 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H2171 | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H2171 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Fulvestrant | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Gefitinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| NCI-H2171 | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | GSK1059615 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| NCI-H2171 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H2171 | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H2171 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | GW441756 | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H2171 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H2171 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H2171 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H2171 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H2171 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H2171 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H2171 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | JNK Inhibitor VIII | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| NCI-H2171 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H2171 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | KU-55933 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H2171 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H2171 | Lenalidomide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Lestaurtinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Linsitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H2171 | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| NCI-H2171 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| NCI-H2171 | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | Methotrexate | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| NCI-H2171 | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H2171 | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| NCI-H2171 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H2171 | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H2171 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | MK-2206 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H2171 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | ML203 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H2171 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H2171 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H2171 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Motesanib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Navitoclax | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H2171 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Nilotinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H2171 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H2171 | NU7441 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Nutlin-3a | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | NVP-TAE684 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H2171 | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Obatoclax Mesylate | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Olaparib | GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H2171 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H2171 | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| NCI-H2171 | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H2171 | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Paclitaxel | GDSC1,GDSC2,CTRP2 | 0.0001 | 66.0000 |
|
| NCI-H2171 | Palbociclib | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H2171 | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H2171 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Parthenolide | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H2171 | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H2171 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PD0325901 | GDSC2 | 0.0025 | 2.5000 |
|
| NCI-H2171 | PD173074 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H2171 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | Pevonedistat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H2171 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H2171 | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Pictilisib | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H2171 | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Piperlongumine | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | PLX-4720 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H2171 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H2171 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H2171 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H2171 | Rapamycin | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H2171 | Refametinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H2171 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H2171 | RO-3306 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | Saracatinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| NCI-H2171 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | SB590885 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H2171 | Selumetinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H2171 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H2171 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H2171 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H2171 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| NCI-H2171 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| NCI-H2171 | Serdemetan | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H2171 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H2171 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H2171 | SL0101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | SN-38 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H2171 | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H2171 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H2171 | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Tamoxifen | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Tanespimycin | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H2171 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Temozolomide | GDSC2,CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H2171 | Temsirolimus | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | TGX221 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H2171 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H2171 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H2171 | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H2171 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H2171 | Tozasertib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | Trametinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H2171 | Tretinoin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| NCI-H2171 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H2171 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H2171 | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | UNC0321 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H2171 | UNC0638 | GDSC1,CTRP2 | 0.0010 | 40.0000 |
|
| NCI-H2171 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H2171 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Veliparib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H2171 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H2171 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H2171 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H2171 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H2171 | Vismodegib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | Vorinostat | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H2171 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| NCI-H2171 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | XAV939 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H2171 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H2171 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H2171 | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H2171 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | YK-4-279 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H2171 | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H2171 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H2171 | ZM447439 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H2171 | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC